Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Researchers at Villanova University in Philadelphia have constructed a model brain they say provides a noninvasive new way to study brain injury. A team of engineers led by…
Early data from the phase III CheckMate 067 trial, reported in September 2017, showed that patients with advanced melanoma treated with nivolumab, with or without ipilimumab, maintained their quality…
For a menopausal woman undergoing hormone therapy, breast cancer risk is significantly influenced by the specific combination of hormones she receives. That’s according to Oxford University scientists who…
Engineers at Massachusetts Institute of Technology have created an ultra-thin, thread-like robot that users can navigate through tiny spaces—including the blood vessels of the human brain. The robot…
Scientists at the University of Florida College of Veterinary Medicine recently discovered that the gut microbiome could help protect pregnant women from malaria. A study in mice found…